SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned.

Publication date: Jul 04, 2024

The coronavirus infectious disease-2019 (COVID-19) in Bangladesh is a paradigm for how one of the most densely populated countries in the world, with 1270 people per square kilometer, managed to cope with the COVID-19 pandemic under extraordinary circumstances. This review highlights the SARS-CoV-2 variants in Bangladesh and the timeline of their detection in the context of the global experience with the management of vaccination and natural SARS-CoV-2 infection. The motivation to overcome the COVID-19 vaccine dilemma and track Bangladeshi SARS-CoV-2 sub-variants underscores the potential for a low-income country to excel in international medical science, despite having stressed health care services and limited availability of resources for SARS-CoV-2 testing and gene sequencing.

Open Access PDF

Concepts	Keywords
Bangladeshi	Bangladesh
Coronavirus	Bangladesh
Pandemic	COVID-19
Science	COVID-19
	COVID-19 Vaccines
	COVID-19 Vaccines
	Humans
	pandemic preparedness
	SARS-CoV-2
	SARS-CoV-2 variants
	vaccination coverage

Semantics

Type	Source	Name
disease	MESH	COVID-19
disease	MESH	infectious disease
pathway	REACTOME	Infectious disease
disease	VO	vaccination
disease	VO	COVID-19 vaccine
disease	IDO	country
disease	VO	gene
drug	DRUGBANK	Coenzyme M
disease	VO	vaccine
disease	VO	vaccination coverage
disease	VO	organization
disease	MESH	emergency
disease	MESH	mutation rate
disease	IDO	process
disease	MESH	infection
disease	IDO	host
disease	VO	population
disease	VO	vaccinated
disease	VO	unvaccinated
disease	MESH	reinfections
disease	VO	ineffective
disease	IDO	cell
disease	VO	effective
disease	VO	USA
disease	VO	immunization
disease	IDO	facility
disease	IDO	production
drug	DRUGBANK	Sulpiride
disease	VO	dose
disease	IDO	replication
drug	DRUGBANK	Chloroquine
drug	DRUGBANK	Hydroxychloroquine
drug	DRUGBANK	Ivermectin
drug	DRUGBANK	Doxycycline
disease	MESH	inflammation
disease	MESH	malignancy
disease	MESH	morbidity
disease	IDO	virulence
disease	MESH	death
drug	DRUGBANK	Angiotensin II
disease	VO	time
disease	MESH	Influenza
disease	VO	frequency
drug	DRUGBANK	Serine
disease	IDO	infectivity
drug	DRUGBANK	Trestolone
drug	DRUGBANK	Oxygen
disease	MESH	fungal infection
disease	VO	volume
disease	MESH	respiratory infections
disease	IDO	blood
disease	MESH	hepatitis
disease	VO	storage
disease	VO	Dengue virus
disease	MESH	dengue
drug	DRUGBANK	Medical air
drug	DRUGBANK	Etoperidone
disease	VO	efficiency
disease	VO	dengue fever vaccine
disease	VO	protocol
disease	VO	vaccine effectiveness
disease	VO	effectiveness
drug	DRUGBANK	Efavirenz
drug	DRUGBANK	Delorazepam
drug	DRUGBANK	Spinosad
drug	DRUGBANK	Isosorbide Mononitrate
drug	DRUGBANK	Vorinostat
disease	VO	Severe acute respiratory syndrome coronavirus 2
disease	IDO	history
drug	DRUGBANK	Guanosine
disease	VO	Equity

Original Article

(Visited 1 times, 1 visits today)